Mylan wins significant summary judgment rulings in kansas epipen® class action

Pittsburgh, june 23, 2021 /prnewswire/ -- viatris (nasdaq: vtrs) today announced that the u.s. district court for the district of kansas ruled, in substantial part, in mylan's favor on the company's summary judgment motion in the class action related to epipen® auto-injector. the company is pleased with the court's decision to dismiss all of the plaintiffs' claims under the federal rico statute, which include claims asserted against mylan's former ceo heather bresch.
VTRS Ratings Summary
VTRS Quant Ranking